Quinolizidine alkaloid biosynthesis: Recent advances and future prospects

82Citations
Citations of this article
138Readers
Mendeley users who have this article in their library.

Abstract

Lys-derived alkaloids, including piperidine, quinolizidine, indolizidine, and lycopodium alkaloids, are widely distributed throughout the plant kingdom. Several of these alkaloids have beneficial properties for humans and have been used in medicine. However, the molecular mechanisms underlying the biosynthesis of these alkaloids are not well understood. In the present article, we discuss recent advances in our understanding of Lys-derived alkaloids, especially the biochemistry, molecular biology, and biotechnology of quinolizidine alkaloid (QA) biosynthesis. We have also highlighted Lys decarboxylase (LDC), the enzyme that catalyzes the first committed step of QA biosynthesis and answers a longstanding question about the molecular entity of LDC activity in plants. Further prospects using current advanced technologies, such as next-generation sequencing, in medicinal plants have also been discussed. © 2012 Bunsupa, Yamazaki and Saito.

Cite

CITATION STYLE

APA

Bunsupa, S., Yamazaki, M., & Saito, K. (2012). Quinolizidine alkaloid biosynthesis: Recent advances and future prospects. Frontiers in Plant Science, 3(OCT). https://doi.org/10.3389/fpls.2012.00239

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free